Back

Glp-1 receptor agonists and cardiovascular outcomes in obese patients on dialysis:insights –from the TriNetX real-world database

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Real-world cardiorenal therapeutics: outcomes and mechanisms in advanced kidney disease Renal Failure and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Beatriz Santana Prado

Hospital Sirio-Libanes, Sao Paulo (Brazil)

8 More presentations in this session

Presentation thumbnail
Intradialytic hypertension drives right ventricular–pulmonary uncoupling: cardiac power index reveals energetic failure in haemodialysis
Doctor M. Merry (Ismailia, EG)
Abstract
Presentation thumbnail
Impact of cumulative contrast volume on medium- to long-term renal function in patients undergoing repeated percutaneous coronary interventions
Doctor P. Steinhoff (Bad Krozingen, DE)
Abstract
Presentation thumbnail
Incidence and predictors of echocardiographic cardiac deterioration after arteriovenous access surgery
Doctor L. Fisher (Ramat Gan, IL)
Abstract
Presentation thumbnail
Longitudinal change in epicardial adipose tissue attenuation on serial non-contrast chest CT in finerenone-treated patients: a real-world cohort study
Doctor X. Zhang (Xi'an, CN)
Abstract
Presentation thumbnail
CV inflammation prevalence and clinical biomarkers (hsCRP, IL-6 and NT-proBNP) levels in adults with ASCVD and CKD in KSA and UAE: Insights from the INFLAMEAST real‑world study
Doctor M. Alasnag (Jeddah, SA)
Abstract

Access the full session

Session thumbnail
Real-world cardiorenal therapeutics: outcomes and mechanisms in advanced kidney disease

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1 receptor agonists as an opportunity for patients with atherosclerotic cardiovascular disease as well as obesity in Germany
1 September 2025
thumbnail
Congress Presentation
The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure
27 August 2021
thumbnail
Congress Presentation
Hemodynamic Changes in response to GLP-1 RA treatment in ICD and CRT patients: Insights from HeartLogic Sensor Data
1 September 2025
thumbnail
Congress Presentation
GLP-1 receptor agonists in cardiorenal disease
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources